China Union: New Carbon-13 Breath Analyzer Approved for Market

Chinese medical technology company Rufu announced on the Hong Kong Stock Exchange that its independently developed new carbon-13 breath analysis instrument has obtained the second-class medical device registration certificate. This achievement represents a breakthrough in technology for detecting Helicobacter pylori in breath, providing a more reliable, efficient, and convenient solution for the diagnosis of Helicobacter pylori.